These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9517881)

  • 1. Pica behavior associated with buprenorphine administration in the rat.
    Bender HM
    Lab Anim Sci; 1998 Feb; 48(1):5. PubMed ID: 9517881
    [No Abstract]   [Full Text] [Related]  

  • 2. Pica behavior associated with buprenorphine administration in the rat.
    Clark JA; Myers PH; Goelz MF; Thigpen JE; Forsythe DB
    Lab Anim Sci; 1997 Jun; 47(3):300-3. PubMed ID: 9241634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's your diagnosis? Respiratory distress in rats.
    Bosgraaf CA; Suchy H; Harrison C; Toth LA
    Lab Anim (NY); 2004 Mar; 33(3):21-2. PubMed ID: 15235624
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of self-injurious behavior, thermal sensitivity, food intake, fecal output, and pica after injection of three buprenorphine formulations in rats (Rattus norvegicus).
    Allen M; Johnson RA
    Am J Vet Res; 2018 Jul; 79(7):697-703. PubMed ID: 29943638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations.
    Thompson AC; Kristal MB; Sallaj A; Acheson A; Martin LB; Martin T
    Comp Med; 2004 Jun; 54(3):293-300. PubMed ID: 15253276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis from buprenorphine.
    Callejo Melgosa AM; Martínez JC; Fuentes MJ; Martín C
    Allergy; 2005 Sep; 60(9):1217-8. PubMed ID: 16076316
    [No Abstract]   [Full Text] [Related]  

  • 7. Buprenorphine produces naltrexone reversible alterations of immune status.
    Carrigan KA; Saurer TB; Ijames SG; Lysle DT
    Int Immunopharmacol; 2004 Mar; 4(3):419-28. PubMed ID: 15037219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic contact dermatitis due to transdermal buprenorphine.
    Pérez-Pérez L; Cabanillas M; Loureiro M; Fernández-Redondo V; Labandeira J; Toribio J
    Contact Dermatitis; 2008 May; 58(5):310-2. PubMed ID: 18416765
    [No Abstract]   [Full Text] [Related]  

  • 9. Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets.
    Feeney GF; Fairweather P
    Drug Alcohol Rev; 2003 Sep; 22(3):359-61. PubMed ID: 15385230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficacy of buprrenorphine in rats.
    Gades NM; Wixson SK; Danneman PJ; Tolley EA
    Contemp Top Lab Anim Sci; 2001 Mar; 40(2):7. PubMed ID: 11345072
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transdermal buprenorphine and silent acute coronary syndrome].
    Vidal MA; Calderón E; Pernia A; Calderón-Pla E; Torres LM
    Rev Esp Anestesiol Reanim; 2006 Jan; 53(1):58-9. PubMed ID: 16475644
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychotic symptoms following buprenorphine withdrawal.
    Karila L; Berlin I; Benyamina A; Reynaud M
    Am J Psychiatry; 2008 Mar; 165(3):400-1. PubMed ID: 18316438
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine withdrawal in a toddler.
    Levine M; Ruha AM
    Ann Emerg Med; 2009 Sep; 54(3):477-8. PubMed ID: 19695424
    [No Abstract]   [Full Text] [Related]  

  • 14. Office-based buprenorphine treatment for opioid-dependent patients.
    McCance-Katz EF
    Harv Rev Psychiatry; 2004; 12(6):321-38. PubMed ID: 15764468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Buprenorphine treatment during pregnancy--risk factors and advantages need to be considered carefully].
    Strengell P; Vahtola M; Tammela O; Seppä K
    Duodecim; 2005; 121(4):392-9. PubMed ID: 15799254
    [No Abstract]   [Full Text] [Related]  

  • 18. [Buprenorphine matrix patch well tolerated. The challenge of tumor pain].
    MMW Fortschr Med; 2006 Jan; 148(1-2):42-3. PubMed ID: 16612846
    [No Abstract]   [Full Text] [Related]  

  • 19. Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats.
    Ceccarelli I; De Padova AM; Fiorenzani P; Massafra C; Aloisi AM
    Neuroscience; 2006 Jul; 140(3):929-37. PubMed ID: 16580783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hyperalgesia properties of buprenorphine.
    Russo MA
    Pain; 2006 May; 122(1-2):216; author reply 216. PubMed ID: 16524662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.